Filing Details
- Accession Number:
- 0001209191-22-010403
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-16 20:10:43
- Reporting Period:
- 2022-02-09
- Accepted Time:
- 2022-02-16 20:10:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124105 | Catalyst Biosciences Inc. | CBIO | Pharmaceutical Preparations (2834) | 562020050 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1769866 | E. Seline Miller | C/O Catalyst Biosciences, Inc. 611 Gateway Boulevard, Suite 710 South San Francisco CA 94080 | Svp Finance; Interim Cfo & Pao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-09 | 3,250 | $0.46 | 3,250 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct |
Footnotes
- Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on February 9, 2022.
Billionaire Hedge Funds
